AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize Asthma and COPD Drug Benralizumab in Japan
Asthma, News
AstraZeneca announced last week it has signed into a partnership with Kyowa Hakko Kirin Co. Ltd. for exclusivity in commercializing benralizumab, a monoclonal antibody currently in Phase III clinical studies as potential ... Read more